ASHLEY KATIC: Open Payments
NPI 1841841673 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 36 payments from 13 companies in 2025. Trend: 2023 $125 · 2024 $39 · 2025 $1,391
Food & beverage: $1,211Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $445 |
| Lilly USA, LLC | 6 | $265 |
| UCB, Inc. | 5 | $176 |
| Arcutis Biotherapeutics, Inc. | 3 | $132 |
| PFIZER INC. | 2 | $86 |
| ABBVIE INC. | 4 | $81 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Blueprint Medicines Corporation | 1 | $29 |
| Genentech USA, Inc. | 1 | $29 |
| LEO Pharma Inc. | 1 | $22 |
Products named: TREMFYA, EBGLYSS, Bimzelx, Zoryve, CIBINQO, DUPIXENT, TALTZ, RINVOQ.
Industry payments across MI — which companies pay providers there.
